U.S. Markets closed

VIVUS, Inc. (VVUS)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.13+0.01 (+0.89%)
At close: 4:00PM EDT
People also watch
OREXARNAKERXAMRNXOMA
Interactive chart
Previous Close1.12
Open1.13
Bid0.80 x 100
Ask1.20 x 500
Day's Range1.11 - 1.14
52 Week Range0.93 - 1.47
Volume630,881
Avg. Volume731,380
Market Cap119.42M
Beta0.52
PE Ratio (TTM)3.42
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Roche (RHHBY) Presents Positive Data on IPF Drug Esbriet
    Zacks2 days ago

    Roche (RHHBY) Presents Positive Data on IPF Drug Esbriet

    Roche Holding AG (RHHBY) announced new retrospective data analyses for idiopathic pulmonary fibrosis (IPF) drug, Esbriet.

  • Inovio (INO) Stock Rises on Encouraging HIV Vaccine Data
    Zacks2 days ago

    Inovio (INO) Stock Rises on Encouraging HIV Vaccine Data

    Inovio Pharmaceuticals Inc. (INO) shares have rallied 12% since the company announced that its HIV vaccine evoked almost 100% immune response rates in a clinical study

  • VIVUS, Inc. :VVUS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
    Capital Cube2 days ago

    VIVUS, Inc. :VVUS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis VIVUS, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of VIVUS, Inc. – Orexigen Therapeutics, Inc., Apricus Biosciences, Inc., Pfizer Inc., AmerisourceBergen Corporation, Eli Lilly and Company, Cardinal Health, Inc., Repros Therapeutics Inc., Sophiris Bio Inc. and Arena Pharmaceuticals, ... Read more (Read more...)